Skip to main content
CRBP logo

CRBP · Corbus Pharmaceuticals Holdings, Inc. · Executive Compensation

Track CRBP — free
$2.06 -0.38 (-15.40%) At close · Nov 20 Q4 2020 earnings call transcript
Market Cap
$42.45M
Shares
20.61M
Volume · Nov 20 1.38M Avg daily vol (3M) 1.1M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Yuval Cohen $3,750,125
Dominic Smethurst $1,800,142
Sean Moran $1,789,423
Fiscal 2024
Executive Total
Yuval Cohen $4,245,438
Dominic Smethurst $2,892,972
Sean Moran $2,429,505
Fiscal 2023
Executive Total
Yuval Cohen $1,137,622
Rachael Brake $839,867
Sean Moran $717,256
Dominic Smethurst —
Fiscal 2022
Executive Total
Yuval Cohen $1,442,841
Sean Moran $778,616
Rachael Brake $763,795
Fiscal 2021
Executive Total
Yuval Cohen $4,858,306
Sean Moran $1,844,917
Rachael Brake $15,807

Executive changes

Person Change Filed
Nishant Saxena Appointed 2026-05-21
Nishant Saxena Appointed 2026-05-21
Brent Pfeiffenberger Appointed 2026-05-14
Dominic Smethurst Resigned 2026-04-07
Alan Holmer
“Mr. Holmer’s decision to resign was not the result of any disagreement with the Company or its management on any matter relating to the Company’s operations, policies or practices.”
Retired 2025-12-18
Ian Hodgson Appointed 2025-03-18
Avery W. Catlin
“Mr. Catlin’s resignation was not the result of any disagreement with the Company on any matters relating to the Company’s operations, policies or practices.”
Resigned 2024-08-20
Winston W. Kung Appointed 2024-08-20
Avery W. Catlin
“Mr. Catlin’s resignation was not the result of any disagreement with the Company on any matters relating to the Company’s operations, policies or practices.”
Resigned 2024-08-20
Yong Ben Appointed 2024-05-20
Anne Altmeyer Already on the board
Since at least 2022: re-election or new board role
2024-05-20
John Jenkins Already on the board
Since at least 2018: re-election or new board role
2024-05-20
Peter Salzmann Already on the board
Since at least 2020: re-election or new board role
2024-05-20
Rachelle Jacques Already on the board
Since at least 2019: re-election or new board role
2024-05-20
Avery W. Catlin Appointed 2024-05-20
Alan Holmer Appointed 2024-05-20
Yuval Cohen Already on the board
Since at least 2014: re-election or new board role
2024-05-20
Rachael Brake, Ph.D. Resigned 2024-02-06
Yong Ben Appointed 2023-03-07
Craig Millian Resigned 2023-03-07
Yong Ben, M.D., MBA Appointed 2023-03-06
Anne Altmeyer, Ph.D., MBA, MPH Appointed 2022-09-26
Craig Millian Appointed 2021-09-28
Barbara White Resigned 2021-08-18

Leadership

Key facts CIK 1595097 CUSIP 21833P301 13F (30d) 129 filings 111 filers Visit website Investor relations